The network tool was used to create a series of network maps for the most commonly reported outcomes. 

Network map of interventions against CD4 cell count at 48 weeks.png uploaded by crystallise
Network map for interventions against CD4 cell count at 96 weeks.png uploaded by crystallise
Network map of interventions against viral suppression at 48 weeks.png uploaded by crystallise
Network map of interventions against viral suppression at 96 weeks.png uploaded by crystallise
Network map for interventions against dicontinuations.png uploaded by crystallise
Network map for interventions against treatment-related adverse events.png uploaded by crystallise
Network map of interventions against 6 most commonly reported outcomes combined.png uploaded by crystallise
Abstract: Planning Phase 3 Clinical Trials More Efficiently Using An Evidence-Mapping Approach.docx uploaded by crystallise
Abstract: The Accuracy Of Network Meta-Analysis Feasibility Predictions Based On Data Included Only In The Abstracts Of Trial Publications.docx uploaded by crystallise
Whitepaper: The Accuracy Of Network Meta-Analysis Feasibility Predictions Based On Data Included Only In The Abstracts Of Trial Publications.pdf uploaded by crystallise